Explore Your Local Site

Looks like you've landed on our   site. Let's take you home:    

Please note that the content and products on the    site might not be available in your region.

 

  Homepage
Continue on the current website:  

 

IB Diffusion

The IB Clinic (Diffusion) module performs post-processing of MR diffusion-weighted image (DWI)

Inquire Now

Imaging Biometrics
  • ADC
  • DWI
  • diffusion
  • Alpha Diffusion
  • DDC

A CNS application that is fundamental for advanced visualization

Using standard algorithms, it generates parametric images such as apparent diffusion coefficient (ADC)

Yellow arrow

DWI is a powerful MRI method that is sensitive to microscopic changes in water mobility and provide insights to treatment response in glioma1

1Schmainda KM. Diffusion-weighted MRI as a biomarker for treatment response in glioma. CNS Oncol. 2012 Nov;1(2):169-80. doi: 10.2217/cns.12.25. PMID: 23936625; PMCID: PMC3734866.

Yellow arrow

Image maps of the apparent diffusion coefficient (ADC), derived from DWI, absolute measures of tissue water diffusion in units of mm2/s on a per-voxel basis1

1Schmainda KM. Diffusion-weighted MRI as a biomarker for treatment response in glioma. CNS Oncol. 2012 Nov;1(2):169-80. doi: 10.2217/cns.12.25. PMID: 23936625; PMCID: PMC3734866.

 

    Vendor Neutral

    Vendor neutral

    IB Diffusion is vendor neutral

    References

    References

    1. IB Clinic 2.0 release 21.12 User Manual
    2. Prah et al, Repeatability of Standardized and Normalized Relative CBV, AJNR Am J Neuroradiology, 2015
    3. Hu, et al, Impact of Software Modeling on the Accuracy of Perfusion MRI, AJNR Am J Neuroradiology, 2015
    4. Schmainda et al, Quantitative Delta T1 (dT1), AJNR Am J Neuroradiology, 2019
    5. Schmainda, Diffusion­ weighted MRI as a biomarker for treatment response in glioma, CNS Oncol, 2012

    What Customers Are Saying

    IB Software ... They have cut down my analysis time from hours to minutes.

    Cathy Marszalkowskl
    Research Coordinator at Froedtert Health, and the Medical College of Wisconsin.

    May not reflect a typical user experience; actual results may vary.

    Request a demo

    See Ahead for Yourself

    Inquire now
    LinkedIn LinkedIn
    Alt tag

    © 2024 Bayer

    The descriptions, claims and visuals for all non-Bayer owned applications originate and are obtained from the application providers, or excerpted from publicly available information. Bayer is providing this content for your information, but does not own and control such content.

    BAYER, the Bayer Cross and Calantic are trademarks owned by Bayer and/or registered in the U.S. and/or other countries. Other trademarks and company names mentioned herein are properties of their respective owners.

    This is intended to provide information for healthcare professionals and other relevant decision makers in the US, European Union, United Kingdom and Switzerland. Not all offerings are available in all markets. For availability specific to your country please contact your local Bayer representative. These materials are exclusively for professional use.

     

    Calantic is ISO 27001 certified. The product Calantic Viewer has CE marking (CE2797). Complies with medical device legislation. Consult the operating instructions of a product for its intended use, characteristics and performance, contraindications, name of the manufacturer or its authorized representative and other essential information. The operating instructions of the product Calantic Viewer can be found on https://www.radiology.bayer.com/manuals

     

    You are encouraged to report adverse events; reporting information can be found on https://www.bayer.com/en/pharma/report-side-effect

    Any individuals depicted in this website are actors and not actual health care providers or patients. All patient data is fictitious. Images are an artistic representation for illustrative purposes only.

     

    Last Updated: April 2024

    Bayer Logo